NYSE:GKOSMedical Equipment
Glaukos (GKOS): Losses Deepen at 14.6% Annual Rate as Bulls Bank on Turnaround Narrative
Glaukos (GKOS) remains unprofitable as losses have increased at a rate of 14.6% per year for the past five years, and the company’s net profit margin has shown no sign of improvement. Despite this trend, earnings are forecast to grow 103.58% per year and Glaukos is expected to become profitable within the next three years. Revenue is projected to climb at 20.5% per year, which is well above the US market average of 10.3% per year. The key debate for investors revolves around these strong...